NCT04823676View on ClinicalTrials.gov

Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL Management

NACompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

March 31, 2021

Primary Completion Date

December 13, 2021

Study Completion Date

February 22, 2022

Conditions

Non Alcoholic Fatty Liver

Interventions

DIETARY_SUPPLEMENT

Probiotic composition

Mixture of two Lactoplantibacillus plantarum strains (formerly Lactobacillus plantarum) and one Levilactobacillus brevis strain (formerly Lactobacillus brevis), in a maltodextrin carrier (E1400)

OTHER

Placebo

Maltodextrin (E1400, qs)

Trial Locations (1)

14080

Hospital General Dr. Manuel Gea Gonzalez, Mexico City

All Listed Sponsors

lead

AB Biotics, SA

INDUSTRY

NCT04823676 - Efficacy and Safety of a Probiotic Composition as Adjunct in MAFL Management | Biotech Hunter | Biotech Hunter